32 reports

Type 1 Diabetes - Epidemiology Forecast to 2029 Summary Type 1 Diabetes (T1D), formerly referred to as insulin-dependent diabetes, is a type of diabetes that predominantly develops in children or young adults before the age of 40 years.The condition, therefore, was also referred to as juvenile diabetes. T1D...

  • Type 1 Diabetes
  • World
  • Diabetes Prevalence
  • Prescription Drug Sales

Global Type 1 Diabetes Drugs Market 2021-2025 The analyst has been monitoring the type 1 diabetes drugs market and it is poised to grow by $ 2.83 billion during 2021-2025, progressing at a CAGR of almost 6% during the forecast period. Our report on the type 1 diabetes drugs market provides a holistic analysis, market size...

  • Type 1 Diabetes
  • World

Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorder) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes - Drugs In Development, 2021, provides an overview of the Type 1 Diabetes (Metabolic Disorders) pipeline landscape.Type 1...

  • Type 1 Diabetes
  • Endocrine Disease
  • World

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes - Pipeline Review, H2 2020, provides an overview of the Type 1 Diabetes (Metabolic Disorders) pipeline landscape. Type 1 diabetes (T1D) is...

  • Type 1 Diabetes
  • Endocrine Disease
  • World

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes – Pipeline Review, H1 2020, provides an overview of the Type 1 Diabetes (Metabolic Disorders) pipeline landscape. Type 1 diabetes (T1D)...

  • Type 1 Diabetes
  • Endocrine Disease
  • World

Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H1, 2020 Summary Clinical trial report, “Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H1, 2020" provides an overview of Type 1 Diabetes (Juvenile Diabetes) Clinical trials scenario.This report provides top...

  • Clinical Trial
  • Type 1 Diabetes
  • World

Gastric Inhibitory Polypeptide Receptor - Drugs In Development, 2021 Summary Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) pipeline Target constitutes close to 26 molecules. Out of which approximately 23 molecules are developed by companies...

  • Type 2 Diabetes
  • Pharmaceutical
  • Diabetes
  • Therapy
  • Drug Development
  • Dementia
  • Type 1 Diabetes
  • Biotechnology
  • World
  • Diabetes Prevalence
  • Energy Consumption

Aryl Hydrocarbon Receptor - Pipeline Review, H2 2020 Summary Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) pipeline Target constitutes close to 27 molecules. Out of which approximately 24 molecules are developed by companies and remaining by the universities/institutes....

  • Therapy
  • Neurological Disorder
  • Dermatological Condition
  • Infectious Disease
  • Autoimmune Disease
  • Pharmaceutical
  • Oncology
  • Type 1 Diabetes
  • Biotechnology
  • World
  • Drug Approval
  • Medical Technology Density

Frontier Pharma: Type 1 Diabetes Insulin Gene Therapy and Immuno-modulators Dominate First-in-Class Pipeline with Novel Target Classes Demonstrating Potential Beta-Cell Regeneration Summary Type 1 diabetes (T1D) is a chronic condition that occurs as a result of the autoimmune destruction of pancreatic...

  • Therapy
  • Type 1 Diabetes
  • World
  • Diabetes Prevalence
  • Prescription Drug Sales

Aryl Hydrocarbon Receptor - Pipeline Review, H1 2020 Summary Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Aryl hydrocarbon receptor is a protein encoded by the AHR gene. It mediates biochemical and toxic effects of halogenated aromatic hydrocarbons....

  • Therapy
  • Neurological Disorder
  • Dermatological Condition
  • Pharmaceutical
  • Autoimmune Disease
  • Oncology
  • Type 1 Diabetes
  • Biotechnology
  • World
  • Drug Approval
  • Medical Technology Density

Blood Glucose Device Market, Users Global Forecast, SMBG Components of 17 Countries (America, Europe, Asia & Pacific, MENA) & Companies According to International diabetes federation, in 2017, there are around 425 million of people living with diabetes in the world. Diabetes people all over the world...

  • Diabetes
  • Diabetes Monitoring
  • Patient Monitoring
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Insulin
  • World
  • China
  • Overweight Prevalence
  • Gross Domestic Product Per Capita

Macrophage Migration Inhibitory Factor - Pipeline Review, H2 2019 Summary Macrophage Migration Inhibitory Factor (Glycosylation Inhibiting Factor or L Dopachrome Isomerase or L Dopachrome Tautomerase or Phenylpyruvate Tautomerase or MIF or EC 5.3.2.1 or EC 5.3.3.12) pipeline Target constitutes close...

  • Autoimmune Disease
  • Arthritis
  • Oncology
  • Type 1 Diabetes
  • Neurological Disorder
  • Prostate Cancer
  • Hypertension
  • Antimalarials
  • World
  • Pharmaceutical Exports
  • Drug Approval

Tumor Necrosis Factor Receptor Superfamily Member 4 - Pipeline Review, H2 2019 Summary Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Tumor Necrosis Factor Receptor Superfamily...

  • Monoclonal Antibody
  • Oncology
  • Therapy
  • Biopharmaceutical
  • Biotechnology
  • Type 1 Diabetes
  • Transplantation
  • World
  • Manufacturing Output

The ongoing clinical trial research report- “2019 Type 1 Diabetes Ongoing Clinical Trials Study” analyzes the current scenario of all active Type 1 Diabetes trials across the world. The report presents top level analysis of global Type 1 Diabetes clinical trials across countries, companies and universities. It is designed to provide clear...

  • Type 1 Diabetes
  • Clinical Trial
  • World
  • APAC

This study covers the world outlook for type 1 diabetes mellitus (T1DM) treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the...

  • Type 1 Diabetes
  • World
  • Gross Domestic Product
  • Disposable Income

Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2029 Summary Type 1 Diabetes (T1D), is an autoimmune disease that permanently destroys beta cells of the pancreatic islet, which means that the body can no longer produce insulin.Insulin is the hormone that is needed for the transport...

  • Type 1 Diabetes
  • World
  • United States
  • Canada
  • Japan
  • Diabetes Prevalence
  • Life Expectancy

Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2018" provides an overview of Type 1 Diabetes (Juvenile Diabetes) clinical trials scenario.This report provides...

  • Clinical Trial
  • Type 1 Diabetes
  • World

Macrophage Migration Inhibitory Factor (Glycosylation Inhibiting Factor or L Dopachrome Isomerase or L Dopachrome Tautomerase or Phenylpyruvate Tautomerase or MIF or EC 5.3.2.1 or EC 5.3.3.12) - Pipeline Review, H2 2018 Summary According to the recently published report ’Macrophage Migration Inhibitory...

  • Immunotherapy
  • Type 1 Diabetes
  • Prostate Cancer
  • Oncology
  • Pharmaceutical
  • Antimalarials
  • World
  • Drug Approval
  • Diagnostic Imaging Density

Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Pipeline Review, H2 2018 Summary Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated...

  • Monoclonal Antibody
  • Oncology
  • Transplantation
  • Type 1 Diabetes
  • World
  • Prescription Drug Sales
  • Drug Approval

Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Pipeline Review, H1 2018 Summary Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Aryl hydrocarbon receptor is a protein encoded by the AHR gene. It mediates biochemical...

  • Oncology
  • Type 1 Diabetes
  • Pharmaceutical
  • Autoimmune Disease
  • Neurological Disorder
  • Transplantation
  • World

Summary Juvenile Diabetes Research Foundation (JDRF) is a research organization that offers funding services for type 1 diabetes.The organization conducts clinical trials for curing, preventing and treating for type 1 diabetes and its complications; and researching new drugs for patients to manage diabetes. It also...

  • Type 1 Diabetes
  • United States
  • Diabetes Prevalence

Summary Orgenesis Inc (Orgenesis) is a biopharmaceutical company that focuses on the development and manufacturing of regenerative cellular therapy and medicine for the treatment of insulin-dependent diabetes patients.The company, through its subsidiaries, offers contract development and manufacturing, and proprietary cell...

  • Cell Therapy
  • Type 1 Diabetes
  • Pharmaceutical
  • Healthcare
  • Private Placement
  • Europe
  • Pharmaceutical Production
  • Birth Rate

Macrophage Migration Inhibitory Factor (Glycosylation Inhibiting Factor or L Dopachrome Isomerase or L Dopachrome Tautomerase or Phenylpyruvate Tautomerase or MIF or EC 5.3.2.1 or EC 5.3.3.12) - Pipeline Review, H1 2018 Summary Macrophage Migration Inhibitory Factor (Glycosylation Inhibiting Factor...

  • Immunotherapy
  • Type 1 Diabetes
  • World
  • Drug Approval

Type 1 Diabetes (Juvenile Diabetes) ongoing clinical trials report provides comprehensive analysis and trends in global Type 1 Diabetes (Juvenile Diabetes) disease clinical trials. The research work analyzes the ongoing Type 1 Diabetes (Juvenile Diabetes) clinical trial trends across countries and companies. The report focuses on drugs...

  • Type 1 Diabetes
  • World

Summary Diamyd Medical AB (Diamyd), formerly Diamyd Therapeutics AB is a drug development company that offers diabetes vaccine.The company’s diabetes products include Diamyd, an antigen-based immunotherapy for the treatment of autoimmune diabetes. Its pipeline products include GAD, GABA, and other immunomodulatory...

  • Type 1 Diabetes
  • Diabetes
  • Vaccine
  • Pharmaceutical
  • Healthcare
  • United States
  • World
  • Vaccination Coverage

Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Pipeline Review, H2 2017 Summary According to the recently published report ’Aryl Hydrocarbon Receptor - Pipeline Review, H2 2017’; Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76...

  • Type 1 Diabetes
  • Pharmaceutical
  • Autoimmune Disease
  • Neurological Disorder
  • World

Summary Genalyte Inc (Genalyte) is a healthcare service provider that develops cancer biomarker panels and testing platforms for screening. The company provides technologies such as the Maverick Detection System and Silicon Photonics Biosensor technology. Its Maverick Detection System quantifies the binding of biomolecules...

  • Diagnostics
  • Arthritis
  • Biomarker
  • Type 1 Diabetes
  • Clinical Trial
  • Molecular Diagnostics
  • United States
  • Medical Devices Sales
  • Health Provider Density

Drug analysis: Farxiga

8770 10000 7800

Drug Overview Farxiga (dapagliflozin; AstraZeneca) is a member of the novel sodium-glucose cotransporter-2 (SGLT-2) inhibitor class. It is approved for the treatment of type 2 diabetes and currently in Phase III trials for the treatment of type 1 diabetes. SGLT-2 inhibitors do not target insulin secretion or...

  • Sodium-Glucose Co-Transporter 2 Inhibitor
  • Type 2 Diabetes
  • Type 1 Diabetes

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Type 1 Diabetes Mellitus in 12 Major Markets Type 1 Diabetes Mellitus (T1DM) is a multisystem disease that progressively destroys the pancreas’ ability to produce insulin. This leads to a chronic condition of defective metabolism of fat, carbohydrates and proteins due to...

  • Type 1 Diabetes
  • Spain
  • United Kingdom
  • United States
  • Italy
  • France
  • Germany
  • China
  • Russia
  • India
  • Canada
  • Japan
  • Brazil
  • Diabetes Prevalence
  • Diabetes Incidence

“Pancreatic Beta-cell Protection Hot Targets & Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of Pancreatic Beta-cell protection. The report covers hot targets & molecules in research for beta-cell protection in both Type-1 diabetes & Type-2 diabetes disease progression. This report...

  • Type 2 Diabetes
  • Diabetes
  • Gene Therapy
  • Insulin
  • Healthcare IT
  • Type 1 Diabetes
  • Biotechnology